Patch clamp studies on the kinetics and selectivity of receptor antagonism by memantine (1-amino-3,5-dimethyladamantan)
References (63)
Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
Eur. J. Pharmac.
(1989)- et al.
Phencyclidine suppresses hippocampal long-term potentiation through stereospecific activation of phencyclidine receptors
Neuropharmacology
(1989) A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task
Pharmac. Biochem. Beh.
(1989)The effect of NMDA antagonists in the radial arm maze task with an interposed delay
Pharmac. Biochem. Beh.
(1990)- et al.
MK-801 blocks NMDA receptor-mediated synaptic transmission and long term potentiation in rat hippocampal slices
Neurosci. Lett.
(1987) - et al.
Low-frequency activation of the NMDA receptor system can prevent the induction of LTP
Neurosci. Lett.
(1989) - et al.
Excitatory amino acid receptors and synaptic plasticity
TIPS
(1990) - et al.
Learning impairment in rats by N-methyl-D-aspartate receptor antagonists
Neuropharmacology
(1988) - et al.
Differences in results from in vivo and in vitro studies on the use-dependency of N-methyl-aspartate antagonism by MK-801 and other phencyclidine receptor ligand
Eur. J. Pharmac.
(1988) - et al.
Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate
Eur. J. Pharmac.
(1991)
The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat
Brain Res.
(1990)
Excitatory amino acids and Alzheimer's disease
Neurobiol. Aging
(1989)
Memantine prevents quinolinic acid-induced hippocampal damage
Eur. J. Pharmac.
(1992)
Memantine displaces 3H-MK-801 at the therapeutic concentrations in postmortem human frontal cortex
Eur. J. Pharmac.
(1989)
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: A human postmortem brain study
Eur. J. Pharmac. Molec. Pharmac.
(1991)
Non-opioid antitussives and methadone differentially influence hippocampal long-term potentiation in freely moving rats
Eur. J. Pharmac.
(1993)
Effects of Competitive and Noncompetitive NMDA Receptor Antagonists on Kindling and LTP
Pharmac. Biochem. Behav.
(1991)
Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones
Neurochem. Int.
(1992)
Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a mutant model of paroxysymal dystonia
Neurosci. Lett.
(1991)
Dextrorphan blocks long- but not short-term memory in a passive avoidance task in rats
Eur. J. Pharmac.
(1991)
Elimination of longterm potentiation in the hippocampus by phencyclidine and ketamine
Brain Res.
(1983)
Blockade of long-term potentiation by phencyclidine and sigma opiates in the hippocampus in vivo and in vitro
Brain Res.
(1983)
Long-term potentiation blocked by phencyclidine and cyclazocine in vitro
Eur. J. Pharmac.
(1984)
Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats
Pharmac. Biochem. Behav.
(1990)
NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine
Brain Res.
(1993)
Ketamine blocks the induction of LTP at the lateral entorhinal cortex-dentate gyrus synapses
Brain Res.
(1992)
Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal neurons
Soc. Neurosci. Abs.
(1991)
Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands
J. Pharmac. Exp. Ther.
(1989)
Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity
J. Neurosci.
(1992)
The time course of glutamate in the synaptic cleft
Science
(1992)
Characteristics of hippocampal primed burst potentiation in vitro and in the awake rat
J. Neurosci.
(1988)
Cited by (260)
Memantine: Updating a rare success story in pro-cognitive therapeutics
2024, NeuropharmacologyMemantine exerts neuroprotective effects by modulating α-synuclein transmission in a parkinsonian model
2021, Experimental NeurologyMemantine ameliorates learning and memory disturbance and the behavioral and psychological symptoms of dementia in thiamine-deficient mice
2019, Pharmacology Biochemistry and Behavior
Copyright © 1993 Published by Elsevier Ltd.